Generation Bio: Novel But Preclinical, Interesting But Without Data (NASDAQ:GBIO)

DNA helix


Generation Bio (NASDAQ:GBIO) says it is a global leader in non-viral DNA therapeutics. Their goal is to “deliver lifelong, titratable gain of function genetic medicines on a disruptive global scale.”

The company has 3 core technologies, described in their

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *